John DiGiovanni
- Cancer Research top 0.2%
- Carcinogens and Genotoxicity Assessment 49
- NF-κB Signaling Pathways 25
- Dermatology top 0.2%
- Oncology top 0.5%
- Cytokine Signaling Pathways and Interactions 31
- Cancer-related Molecular Pathways 20
- Immunology top 1%
- Molecular Biology top 0.5%
- PI3K/AKT/mTOR signaling in cancer 35
- DNA Repair Mechanisms 25
- Genomics, phytochemicals, and oxidative stress 17
- Melanoma and MAPK Pathways 14
- Co-authors
- Kaoru KiguchiShigetoshi SanoSteve CarbajalKeith Syson ChanLinda BeltránThomas J. SlagaJoe M. AngelAchinto Saha
- Cited by
- Cancer ResearchDermatologyOncology
- Partner nations
- United StatesJapanUnited Kingdom
In The Last Decade
John DiGiovanni
320 papers receiving 12.3k citations
Hit Papers
Peers
Comparison fields: 5 of 143
- Cancer Research 3.1k
- Dermatology 1.2k
- Oncology 3.5k
- Immunology 2.2k
- Molecular Biology 6.6k
Countries citing papers authored by John DiGiovanni
This map shows the geographic impact of John DiGiovanni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John DiGiovanni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John DiGiovanni more than expected).
Fields of papers citing papers by John DiGiovanni
This network shows the impact of papers produced by John DiGiovanni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John DiGiovanni. The network helps show where John DiGiovanni may publish in the future.
Co-authorship network
The 25 scholars most cited alongside John DiGiovanni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 10 | |
| 2 | 2023 | 8 | |
| 3 | 2023 | 2 | |
| 4 | 2021 | 23 | |
| 5 | 2017 | 78 | |
| 6 | 2015 | 38 | |
| 7 | 2015 | 35 | |
| 8 | 2014 | 116 | |
| 9 | 2013 | 35 | |
| 10 | 2013 | 44 | |
| 11 | 2012 | 23 | |
| 12 | 2012 | 53 | |
| 13 | 2011 | 41 | |
| 14 | 2011 | 60 | |
| 15 | 2011 | 52 | |
| 16 | 2010 | 13 | |
| 17 | 2010 | 14 | |
| 18 | 2009 | 20 | |
| 19 | 2007 | 78 | |
| 20 | 2006 | 48 |
About John DiGiovanni
John DiGiovanni is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 322 papers that have together received 12.6k indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (49 papers), PI3K/AKT/mTOR signaling in cancer (35 papers), Cytokine Signaling Pathways and Interactions (31 papers), NF-κB Signaling Pathways (25 papers), DNA Repair Mechanisms (25 papers), Cancer-related Molecular Pathways (20 papers), Genomics, phytochemicals, and oxidative stress (17 papers) and Melanoma and MAPK Pathways (14 papers). The work is most often cited by research in Cancer Research (3.1k citations), Dermatology (1.2k citations) and Oncology (3.5k citations). John DiGiovanni has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include Kaoru Kiguchi, Shigetoshi Sano, Steve Carbajal, Keith Syson Chan, Linda Beltrán, Thomas J. Slaga, Joe M. Angel, Achinto Saha, Erika L. Abel and Mikhail G. Kolonin. Their work appears in journals such as Molecular Carcinogenesis, Carcinogenesis, Cancer Research, Chemical Research in Toxicology and Cancer Prevention Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.